FDA Adverse Event Other Summary report: N

HYDRELLE

MDR report key: 1833859 · Received September 7, 2010

Report

Report Number
1223628-2010-00117
Event Type
Other
Date Received
September 7, 2010
Date of Event
July 13, 2009
Report Date
August 31, 2010
Manufacturer
ANIKA THERAPEUTICS, INC.
Product Code
LMH
PMA / PMN Number
050033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DR. (B)(6) DID NOT REPORT THE COMPLAINT AT THE TIME OF THE ADVERSE EVENT ((B)(6) 2009) BECAUSE HE DID THINK THE PATIENT REACTION WAS RELATED TO HYDRELLE UNTIL HE RECEIVED ANOTHER PATIENT REACTION IN (B)(6) OF 2010. PER PRODUCT LABELING, THE PRODUCT IS INDICATED FOR USE IN THE MID TO DEEP DERMIS FOR THE CORRECTION OF MODERATE TO SEVERE FACIAL WRINKLES AND FOLDS SUCH AS NASOLABIAL FOLDS.

Description of Event or Problem · 1

PATIENT DEVELOPED LATE INFECTION IN THEIR NASAL LABIAL FOLDS 6 MONTHS AFTER THE INJECTION. PATIENT ABSCESS INCISED AND DRAINED. AUGMENTIN WAS GIVEN TO THE PATIENT AND INFECTION RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HYDRELLE IMPLANT, DERMAL FOR AESTHETIC USE LMH ANIKA THERAPEUTICS, INC. 685-015 V080099AA

Patients

Seq Age Sex Outcome Treatment
1 36 YR Required Intervention